1. Recent Product Monograph updates in Canada

   News item 15 September 2018 Pages: 1 - 1

2. Risk of serious rare infection with SGLT2 inhibitors

   News item 15 September 2018 Pages: 2 - 2

3. ACTZ vs mannitol for cisplatin-induced nephrotoxicity

   Clinical study 15 September 2018 Pages: 3 - 3

4. ADR data via social media compared with standard sources

   Clinical study 15 September 2018 Pages: 4 - 4

5. Bleomycin: low-risk therapy for good-risk testicular cancer

   Clinical study 15 September 2018 Pages: 5 - 5

6. Diclofenac linked with risk of major adverse CV events

   Clinical study 15 September 2018 Pages: 6 - 6

7. Disproportionality analysis reveals new AEs for levonorgestrel

   Review 15 September 2018 Pages: 7 - 7

8. Drug utilisation in pregnant women in Burkina Faso analysed

   Clinical study 15 September 2018 Pages: 8 - 8

9. Infection-related costs higher with dasatinib than nilotinib

   Clinical study 15 September 2018 Pages: 9 - 9

10. No increased risk of dementia/AD with long-term PPIs

    Clinical study 15 September 2018 Pages: 10 - 10

11. Point-of-care renal function test saves AE-related costs

    Clinical study 15 September 2018 Pages: 11 - 11

12. Rivaroxaban: no reduction in death rate or increase in major bleeding

    Clinical study 15 September 2018 Pages: 12 - 12

13. Abatacept

    Case report 15 September 2018 Pages: 13 - 13

14. Acenocoumarol overdose

    Case report 15 September 2018 Pages: 14 - 14

15. Acenocoumarol/enoxaparin sodium

    Case report 15 September 2018 Pages: 15 - 15

16. Adalimumab

    Case report 15 September 2018 Pages: 16 - 16

17. Adalimumab

    Case report 15 September 2018 Pages: 17 - 17

18. Afatinib

    Case report 15 September 2018 Pages: 18 - 18

19. Aldesleukin

    Case report 15 September 2018 Pages: 19 - 19

20. Alemtuzumab/fingolimod/methylprednisolone

    Case report 15 September 2018 Pages: 20 - 20

21. Alteplase

    Case report 15 September 2018 Pages: 21 - 21

22. Alteplase/rivaroxaban

    Case report 15 September 2018 Pages: 22 - 22

23. Amantadine

    Case report 15 September 2018 Pages: 23 - 23

24. Amikacin/amoxicillin

    Case report 15 September 2018 Pages: 24 - 24

25. Amikacin/ciprofloxacin/levofloxacin

    Case report 15 September 2018 Pages: 25 - 25

26. Amiodarone

    Case report 15 September 2018 Pages: 26 - 26

27. Amiodarone

    Case report 15 September 2018 Pages: 27 - 27

28. Anaesthetics

    Case report 15 September 2018 Pages: 28 - 28

29. Anakinra/celecoxib

    Case report 15 September 2018 Pages: 29 - 29

30. Anti-psoriatic drugs

    Case report 15 September 2018 Pages: 30 - 30

31. Antibacterials

    Case report 15 September 2018 Pages: 31 - 31

32. Antibacterials

    Case report 15 September 2018 Pages: 32 - 32

33. Antibacterials/carbamazepine/clotiapine

    Case report 15 September 2018 Pages: 33 - 33

34. Antiepileptics

    Case report 15 September 2018 Pages: 34 - 34

35. Antineoplastics

    Case report 15 September 2018 Pages: 35 - 35

36. Antineoplastics

    Case report 15 September 2018 Pages: 36 - 36

37. Antineoplastics

    Case report 15 September 2018 Pages: 37 - 37

38. Antineoplastics

    Case report 15 September 2018 Pages: 38 - 38

39. Antineoplastics

    Case report 15 September 2018 Pages: 39 - 39

40. Antineoplastics

    Case report 15 September 2018 Pages: 40 - 40

41. Antineoplastics

    Case report 15 September 2018 Pages: 41 - 41

42. Antineoplastics

    Case report 15 September 2018 Pages: 42 - 42

43. Antineoplastics

    Case report 15 September 2018 Pages: 43 - 43

44. Antipsychotics

    Case report 15 September 2018 Pages: 44 - 44

45. Antithymocyte globulin/ciclosporin

    Case report 15 September 2018 Pages: 45 - 45

46. Antituberculars

    Case report 15 September 2018 Pages: 46 - 46

47. Apixaban

    Case report 15 September 2018 Pages: 47 - 47

48. Aripiprazole

    Case report 15 September 2018 Pages: 48 - 48

49. Aspirin/dabigatran-etexilate

    Case report 15 September 2018 Pages: 49 - 49

50. Aspirin/low molecular weight heparin

    Case report 15 September 2018 Pages: 50 - 50